- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00920881
Clinical Evaluation of the Accuracy of the FreeStyle Navigator Continuous Glucose Monitoring System
June 11, 2009 updated by: Abbott Diabetes Care
Protocol #TS05-066 Clinical Evaluation of the Accuracy of the FreeStyle Navigator Continuous Glucose Monitoring System
To evaluate the clinical accuracy of the FreeStyle Navigator Continuous Glucose Monitoring System with respect to a reference standard.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
58
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Walnut Creek, California, United States, 94598
- Diablo Clinical Research
-
-
Texas
-
San Antonio, Texas, United States, 78229
- Diabetes & Glandular Disease Clinic
-
-
Washington
-
Renton, Washington, United States, 98055
- Ranier Clinical Research
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Subjects recruited from clinical research centers which specialize in diabetes-related therapies.
Description
Inclusion Criteria:
- History consistent with type 1 diabetes
- At least 18 years of age
- Available and capable of following the protocol instructions provided by the healthcare professional
- Signed and dated informed consent form
Exclusion Criteria:
- Pregnancy
- Type 2, gestational, or secondary diabetes
- Known allergy to medical grade adhesives
- Skin abnormalities at the insertion sites that would confound the assessment of the effect of the device on the skin
- Seizure disorder
- Myocardial ischemia
- History of stroke
- Severe hypoglycemia unawareness
- Other concomitant medical conditions that in the opinion of the investigator, would affect the evaluation of device performance and/or safety
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Diabetes
|
Subjects wore 2 Navigator sensors for approximately 122 hours.
Subjects and clinical staff were masked to continuous glucose data.
During the time the subjects wore the continuous sensor, they were instructed to continue with their current diabetes management plan.
Subjects stayed at the clinic for approximately 50 hours during the study period.
While in the clinic, venous blood samples were collected every 15 minutes to determine whole blood reference glucose concentrations using the Yellow Springs Instrument.
Subjects were also asked to obtain up to 50 FreeStyle finger blood glucose measurements using the system in the Navigator receiver for comparative analysis and system calibration.
This was not a treatment study.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Weinstein RL, Schwartz SL, Brazg RL, Bugler JR, Peyser TA, McGarraugh GV. Accuracy of the 5-day FreeStyle Navigator Continuous Glucose Monitoring System: comparison with frequent laboratory reference measurements. Diabetes Care. 2007 May;30(5):1125-30. doi: 10.2337/dc06-1602. Epub 2007 Mar 2.
- McGarraugh G, Bergenstal R. Detection of hypoglycemia with continuous interstitial and traditional blood glucose monitoring using the FreeStyle Navigator Continuous Glucose Monitoring System. Diabetes Technol Ther. 2009 Mar;11(3):145-50. doi: 10.1089/dia.2008.0047.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2005
Primary Completion (ACTUAL)
December 1, 2005
Study Completion (ACTUAL)
December 1, 2005
Study Registration Dates
First Submitted
June 11, 2009
First Submitted That Met QC Criteria
June 11, 2009
First Posted (ESTIMATE)
June 15, 2009
Study Record Updates
Last Update Posted (ESTIMATE)
June 15, 2009
Last Update Submitted That Met QC Criteria
June 11, 2009
Last Verified
June 1, 2009
More Information
Terms related to this study
Other Study ID Numbers
- TS05-066
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
Medical College of WisconsinMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Medical College of WisconsinMedical University of South Carolina; National Institute of Diabetes and Digestive...Active, not recruitingDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
Medical College of WisconsinNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
Clinical Trials on FreeStyle Navigator Continuous Glucose Monitoring System
-
Abbott Diabetes CareLiverpool University Hospitals NHS Foundation Trust; NHS Lothian; Cardiff and... and other collaboratorsCompletedDiabetes MellitusUnited Kingdom
-
Jaeb Center for Health ResearchNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Insulin-DependentUnited States
-
University Medical Centre LjubljanaKarolinska Institutet; Schneider Children's Medical Center, IsraelCompletedHypoglycemia | Diabetes Mellitus, Type 1Sweden, Israel, Slovenia
-
Jaeb Center for Health ResearchNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 1United States
-
Abbott Diabetes CareCompleted
-
Charles University, Czech RepublicUnknown
-
Charles University, Czech RepublicUnknownDiabetes Mellitus, Type 1Czechia
-
Stanford UniversitySanta Clara Valley Health & Hospital SystemCompletedInsulin ResistanceUnited States
-
Jaeb Center for Health ResearchJDRF Artificial Pancreas ProjectCompletedHealthy Subjects Without Type 1 DiabetesUnited States